Patrick Campbell is the assistant managing editor of Endocrinology Network, as well as its sister publication Practical Cardiology. Prior to joining these brands, he led coverage of cardiology and diabetes with HCPLive. Before joining parent company MJH Life Sciences in 2019, he spent time as a beat reporter with the Pocono Record in Stroudsburg, PA, and Star News Group in Manasquan, NJ. He also touts experience in multimedia, having spent time as a freelance multimedia specialist with NJ Advance Media and multimedia coordinator at the Pocono Record.  Follow him on Twitter @RealPatCampbell or reach him via email at PCampbell@mjhlifesciences.com.

Articles

The US Preventive Services Task Force has issued a B-graded recommendation statement lowering their recommended age for screening for type 2 diabetes from 40 to 35 years.

USPSTF Lowers Recommended Screening Age for Type 2 Diabetes

The latest recommendation statement reaffirms the USPSTF's 2014 guidance, which included a B recommendation for screening for gestational diabetes at 24 weeks of gestation or after. 

USPSTF Reaffirms 2014 Guidance on Screening for Gestational Diabetes

The USPSTF has issued the organization's first recommendation on interventions for promoting healthy weight gain during pregnancy and also provided an overview of the evidence base used for the recommendation statement.

USPSTF Issues Recommendation on Interventions for Healthy Weight Gain During Pregnancy

Dr. Gregory Weiss offers perspective on a recent guideline update from the American Heart Association outlining strategies to best manage risk of cardiovascular disease in women entering menopause. 

Physician Perspective: AHA Guidelines on Managing CVD Risk During Menopause

An analysis from ESC Congress 2020 is shedding further light on the effects of dulaglutide in patients with and without background metformin use. 

CV Benefit of Dulaglutide Present Regardless of Background Metformin Use

The MiniMed 770G becomes the first system to receive approval for children in this age group. 

Medtronic's MiniMed 770G Receives FDA Approval in Children 2 to 6 Years Old

A randomized trial found use of a closed-loop insulin delivery system was safe and effective in type 1 diabetics as young as 6 years of age. 

Artificial Pancreas Proven Safe and Effective in Diabetics 6 Years and Older

An endocrinologist from New Jersey discusses the importance of flu shots in high-risk diabetic patients.

Melissa Young, MD: The Importance of Flu Shots in High Risk Diabetics

New data suggests bone density measurement follow-ups within 3 years of baseline assessment are unnecessary and a potential misuse of resources. 

Three-Year Bone Density Follow-ups Do Not Increase Risk Prediction Accuracy

New data disputes the findings of previous observational studies examining the effects of levothyroxine on cardiac function. 

Clinical Guidelines